首页>外文期刊>Translational Medicine Communications

Translational Medicine Communications

Translational Medicine Communications

中文名称：转化医学通讯

ISSN：2396-832X
出版周期：-

发文量：84

期刊论文

年度选择

2024
- 第1期
2023
- 第1期
2022
- 第1期
2021
- 第1期
2020
- 第1期
2019
- 第1期
2018
- 第1期
2017
- 第1期
2016
- 第1期

更多>>

全选（0）

1.Comments on the optimal use of medical ozone in clinics versus the Ozone High Dose Therapy (OHT) approach
- 期刊名称：《Translational Medicine Communications》 | 2022年第1期
2.The effects of an SPM-enriched marine oil and bioavailable curcumin combination on inflammation-associated discomfort in generally healthy individuals: a virtual open-label pilot study
- 期刊名称：《Translational Medicine Communications》 | 2022年第1期
- Inflammation;
- Pro-resolving mediators;
- Curcumin;
- Pain/discomfort;
3.Imaged-guided focused ultrasound in combination with various formulations of doxorubicin for the treatment of diffuse intrinsic pontine glioma
- 期刊名称：《Translational Medicine Communications》 | 2022年第1期
- Diffuse intrinsic pontine glioma;
- Focused ultrasound;
- Blood–brain barrier;
- Liposomes;
- Nanomedicine;
- Doxorubicin;
- Drug delivery;
4.Targeted quantitation of CFTR protein expression in vivo using immunoprecipitation parallel reaction monitoring tandem mass spectrometry
- 期刊名称：《Translational Medicine Communications》 | 2022年第1期
- CFTR;
- CF disease;
- mRNA therapeutic;
- Membrane protein;
- Immunoprecipitation;
- LC–MS/MS;
- Tissue;
- Protein quantification;
5.Association of the rs4646994 in ACE gene with susceptibility to tuberculosis in a region of the Brazilian Amazon
- 期刊名称：《Translational Medicine Communications》 | 2022年第1期
- Tuberculosis;
- Susceptibility;
- INDEL;
- Polymorphisms;
- ACE;
6.Characterization of a small molecule modulator of inflammatory cytokine production
- 期刊名称：《Translational Medicine Communications》 | 2022年第1期
- GLS-1027;
- Pro-inflammatory cytokines;
- Inflammation;
- Th17 cells;
- Type 1 diabetes mellitus;
- NOD mice;
- Inflammatory disorders;
7.Prevalence of different patterns of dyslipidemia in patients with type 2 diabetes in an Iranian population
- 期刊名称：《Translational Medicine Communications》 | 2022年第1期
- Diabetes;
- Single dyslipidemia;
- Mixed dyslipidemia;
- Atherogenic index of plasma;
8.Planning preclinical confirmatory multicenter trials to strengthen translation from basic to clinical research – a multi-stakeholder workshop report
- 期刊名称：《Translational Medicine Communications》 | 2022年第1期
9.Adoption of telehealth technologies: an approach to improving healthcare system
- 期刊名称：《Translational Medicine Communications》 | 2022年第1期
- Telehealth;
- Pandemic;
- Sustainable development;
- Policymaking;
10.Integrated analysis of clinical, bioelectrical and functional variables in newly diagnosed lung cancer adult patients: pilot study
- 期刊名称：《Translational Medicine Communications》 | 2022年第1期
11.Promises of eukaryotic ribonucleases for cancer treatment: a systematic review
- 期刊名称：《Translational Medicine Communications》 | 2022年第1期
- Anticancer;
- Metastasis;
- Onconase®;
- RNase;
- Secretary Ribonucleases;
12.COVID-19: positive experience with differentiated tactics of mechanical ventilation of the lungs for different phenotypes (L-phenotype)
- 期刊名称：《Translational Medicine Communications》 | 2022年第1期
- CoVID-19 pneumonia;
- Acute Respiratory Distress Syndrome (ARDS);
- Type L;
- Mechanical ventilation of the lungs;
13.Global conserved RBD fraction of SARS-CoV-2 S-protein with T500S mutation in silico significantly blocks ACE2 and rejects viral spike
- 期刊名称：《Translational Medicine Communications》 | 2022年第1期
- SARS CoV-2 pandemic;
- ACE2 blocking by RBD fragments;
- Mutation in RBD;
- T500S;
- Haddock and Hawkdock;
14.A phase I/II study of adoptive immunotherapy using donor liver graft-derived natural killer cells to prevent bloodstream infection after liver transplantation: a study protocol
- 期刊名称：《Translational Medicine Communications》 | 2022年第1期
- Immunotherapy;
- NK cell;
- Liver transplantation;
- Bloodstream infection;
15.Quantitative urine proteomics in pregnant women for the identification of predictive biomarkers for preeclampsia
- 期刊名称：《Translational Medicine Communications》 | 2022年第1期
- Preeclampsia;
- Prediction;
- Biomarkers;
- Proteomics;
- Mass spectrometry;
- Urine;
16.Comparison of gene expression between human and mouse iPSC-derived cardiomyocytes for stem cell therapies of cardiovascular defects via bioinformatic analysis
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
- Bioinformatics;
- iPSCs;
- Cardiomyocytes;
- Enrichment analysis;
- Cardiovascular disease;
17.Validation of the media fill method for Cytokine-Induced killer cells manufacturing process
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
- Validation;
- Good manufacturing process;
- ATMP;
18.Antimicrobial peptide Mastoparan X has good activity against Escherichia coli in vitro and alleviates its pathogenicity in mice
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
- Antimicrobial peptide MPX;
- Escherichia coli;
- IPEC-J2 cells;
- Pathogenicity;
- Mice;
19.Exploring the clinical and genetical spectrum of ADPKD in Chile to assess ProPKD score as a risk prediction tool
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
- ADPKD;
- Genetic analysis;
- End-stage renal disease;
- ProPKD score;
20.Translational research and key aspects to make it successful
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
- Translational research;
- Leadership;
- Project management;
- Communication;
21.Expression of HIF-1α and markers of angiogenesis and metabolic adaptation in molecular subtypes of breast cancer
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
22.Is post-transplant day + 14 immature reticulocyte fraction (IRF) a reliable surrogate marker for predicting early platelet engraftment in pediatric hematopoietic stem cell transplant?
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
23.Non-invasive monitoring of pulmonary blood flow, functional residual capacity, and shunt index in a porcine model
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
24.Impact of clonal hematopoiesis in COVID-19 patients at high risk for adverse clinical outcomes
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
- Clonal hematopoiesis;
- COVID-19;
- Chronic kidney disease;
25.Meta-analysis of preclinical measures of efficacy in immune checkpoint blockade therapies and comparison to clinical efficacy estimates
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
26.Targeting EphA2 and DDR signaling can overcome the BRAF and MEK inhibitors acquired resistance in melanoma cell lines
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
27.RLS-0071, a dual-targeting anti-inflammatory peptide - biomarker findings from a first in human clinical trial
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
- RLS-0071;
- Healthy volunteer;
- Complement;
- MPO;
- NETosis;
- Phase 1;
- Single ascending dose;
- Multiple ascending dose;
28.Methotrexate intolerance in Rheumatoid Arthritis
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
- Methotrexate;
- Rheumatoid Arthritis;
- Intolerance;
- Therapy;
29.Protection of lipopolysaccharide-induced otic injury by a single dose administration of a novel dexamethasone formulation
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
- Corticosteroids;
- Bacterial infection;
- DEX-nanoformulation;
- Inflammation;
- Innate immune response;
- MRI;
- TLR;
- Strial vascular permeability;
30.Mapping the knowledge structure of a gluten-free diet: a global perspective
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
- Gluten-free diet;
- Scopus;
- VOSviewer;
- Bibliometric;
- Global;
31.Unraveling the complexity: understanding the deconvolutions of RNA-seq data
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
- Deconvolution techniques;
- RNA-seq data analysis;
- Differential gene expression analysis;
- Transcriptome profiling;
- CIBERSORT;
- xCell;
- MCP-counter;
32.Accessing and utilizing clinical and genomic data from an electronic health record data warehouse
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
- Electronic health record;
- Data warehouse;
- Big data;
- Genomics;
33.Killer cell immunoglobulin receptor diversity and its relevance in the human host’s response to HIV infection in African populations
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
34.A window of opportunity trial evaluating intratumoral injection of Copaxone® in patients with percutaneously accessible tumors
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
35.Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford Health
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
- Cancer gene therapy;
- Oncolytic adenovirus;
- Suicide gene therapy;
- Adenoviral gene therapy;
36.Adenosine, Lidocaine and Magnesium (ALM) therapy modulates early sex-specific inflammatory and immune responses following experimental anterior cruciate ligament rupture and reconstruction
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
- Anterior cruciate ligament;
- ACL rupture;
- ACL reconstruction;
- Sex differences;
- Inflammation;
37.Feasibility of manufacture of chimeric antigen receptor-regulatory T cells from patients with end-stage renal disease
- 期刊名称：《Translational Medicine Communications》 | 2023年第1期
- CAR-Tregs;
- Manufacturing;
- End-stage renal disease;
- HLA-A*02 mismatch;
- Immunotherapy;

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有出版物经营许可证

客服微信
服务号